These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 16317585

  • 1. PIK3CA mutations in breast cancer are associated with poor outcome.
    Li SY, Rong M, Grieu F, Iacopetta B.
    Breast Cancer Res Treat; 2006 Mar; 96(1):91-5. PubMed ID: 16317585
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women.
    Maruyama N, Miyoshi Y, Taguchi T, Tamaki Y, Monden M, Noguchi S.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):408-14. PubMed ID: 17202311
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas.
    Barbareschi M, Buttitta F, Felicioni L, Cotrupi S, Barassi F, Del Grammastro M, Ferro A, Dalla Palma P, Galligioni E, Marchetti A.
    Clin Cancer Res; 2007 Oct 15; 13(20):6064-9. PubMed ID: 17947469
    [Abstract] [Full Text] [Related]

  • 5. PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma.
    Buttitta F, Felicioni L, Barassi F, Martella C, Paolizzi D, Fresu G, Salvatore S, Cuccurullo F, Mezzetti A, Campani D, Marchetti A.
    J Pathol; 2006 Feb 15; 208(3):350-5. PubMed ID: 16353168
    [Abstract] [Full Text] [Related]

  • 6. PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients.
    Lai YL, Mau BL, Cheng WH, Chen HM, Chiu HH, Tzen CY.
    Ann Surg Oncol; 2008 Apr 15; 15(4):1064-9. PubMed ID: 18183466
    [Abstract] [Full Text] [Related]

  • 7. Frequent mutation of the PIK3CA gene in ovarian and breast cancers.
    Levine DA, Bogomolniy F, Yee CJ, Lash A, Barakat RR, Borgen PI, Boyd J.
    Clin Cancer Res; 2005 Apr 15; 11(8):2875-8. PubMed ID: 15837735
    [Abstract] [Full Text] [Related]

  • 8. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
    Ching-Shian Leong V, Jabal MF, Leong PP, Abdullah MA, Gul YA, Seow HF.
    Cancer Genet Cytogenet; 2008 Dec 15; 187(2):74-9. PubMed ID: 19027487
    [Abstract] [Full Text] [Related]

  • 9. Mutation of the PIK3CA gene in ovarian and breast cancer.
    Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS, Cristiano BE, Pearson RB, Phillips WA.
    Cancer Res; 2004 Nov 01; 64(21):7678-81. PubMed ID: 15520168
    [Abstract] [Full Text] [Related]

  • 10. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
    Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.
    Oncogene; 2005 Feb 17; 24(8):1477-80. PubMed ID: 15608678
    [Abstract] [Full Text] [Related]

  • 11. PIK3CA gene mutations in pediatric and adult glioblastoma multiforme.
    Gallia GL, Rand V, Siu IM, Eberhart CG, James CD, Marie SK, Oba-Shinjo SM, Carlotti CG, Caballero OL, Simpson AJ, Brock MV, Massion PP, Carson BS, Riggins GJ.
    Mol Cancer Res; 2006 Oct 17; 4(10):709-14. PubMed ID: 17050665
    [Abstract] [Full Text] [Related]

  • 12. Rare PIK3CA hotspot mutations in carcinomas of the biliary tract.
    Riener MO, Bawohl M, Clavien PA, Jochum W.
    Genes Chromosomes Cancer; 2008 May 17; 47(5):363-7. PubMed ID: 18181165
    [Abstract] [Full Text] [Related]

  • 13. [PIK3CA mutation is an independent indicator of malignant phenotype and prognosis in breast cancer].
    Li SY, Wang W, Li JM, Wang Z, Wen RY, Chen J, Miao XT.
    Zhonghua Zhong Liu Za Zhi; 2011 Aug 17; 33(8):605-8. PubMed ID: 22325221
    [Abstract] [Full Text] [Related]

  • 14. PIK3CA mutations in glioblastoma multiforme.
    Hartmann C, Bartels G, Gehlhaar C, Holtkamp N, von Deimling A.
    Acta Neuropathol; 2005 Jun 17; 109(6):639-42. PubMed ID: 15924253
    [Abstract] [Full Text] [Related]

  • 15. Mutation of PIK3CA: possible risk factor for cervical carcinogenesis in older women.
    Cui B, Zheng B, Zhang X, Stendahl U, Andersson S, Wallin KL.
    Int J Oncol; 2009 Feb 17; 34(2):409-16. PubMed ID: 19148475
    [Abstract] [Full Text] [Related]

  • 16. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y, Yao L, Li H, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Larsson O, Xie Y.
    Breast Cancer Res Treat; 2006 May 17; 97(1):49-55. PubMed ID: 16319978
    [Abstract] [Full Text] [Related]

  • 17. Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.
    Baselga J, Semiglazov V, van Dam P, Manikhas A, Bellet M, Mayordomo J, Campone M, Kubista E, Greil R, Bianchi G, Steinseifer J, Molloy B, Tokaji E, Gardner H, Phillips P, Stumm M, Lane HA, Dixon JM, Jonat W, Rugo HS.
    J Clin Oncol; 2009 Jun 01; 27(16):2630-7. PubMed ID: 19380449
    [Abstract] [Full Text] [Related]

  • 18. Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines.
    Hollestelle A, Elstrodt F, Nagel JH, Kallemeijn WW, Schutte M.
    Mol Cancer Res; 2007 Feb 01; 5(2):195-201. PubMed ID: 17314276
    [Abstract] [Full Text] [Related]

  • 19. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations.
    Kehr EL, Jorns JM, Ang D, Warrick A, Neff T, Degnin M, Lewis R, Beadling C, Corless CL, Troxell ML.
    Hum Pathol; 2012 Dec 01; 43(12):2207-12. PubMed ID: 22705004
    [Abstract] [Full Text] [Related]

  • 20. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
    Fenic I, Steger K, Gruber C, Arens C, Woenckhaus J.
    Oncol Rep; 2007 Jul 01; 18(1):253-9. PubMed ID: 17549376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.